KR20190024420A - Manufacturing method of soybean-yogurt improved taste and increased number of viable lactic acid bacteria - Google Patents
Manufacturing method of soybean-yogurt improved taste and increased number of viable lactic acid bacteria Download PDFInfo
- Publication number
- KR20190024420A KR20190024420A KR1020170111402A KR20170111402A KR20190024420A KR 20190024420 A KR20190024420 A KR 20190024420A KR 1020170111402 A KR1020170111402 A KR 1020170111402A KR 20170111402 A KR20170111402 A KR 20170111402A KR 20190024420 A KR20190024420 A KR 20190024420A
- Authority
- KR
- South Korea
- Prior art keywords
- soybean
- lactic acid
- acid bacteria
- weight
- soybean milk
- Prior art date
Links
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 title claims description 100
- 241000894006 Bacteria Species 0.000 title claims description 53
- 239000004310 lactic acid Substances 0.000 title claims description 50
- 235000014655 lactic acid Nutrition 0.000 title claims description 50
- 238000004519 manufacturing process Methods 0.000 title abstract description 9
- 235000019640 taste Nutrition 0.000 title description 8
- 230000001965 increasing effect Effects 0.000 title description 7
- 235000010469 Glycine max Nutrition 0.000 claims abstract description 120
- 244000068988 Glycine max Species 0.000 claims abstract description 111
- 210000004080 milk Anatomy 0.000 claims abstract description 58
- 239000008267 milk Substances 0.000 claims abstract description 54
- 235000013336 milk Nutrition 0.000 claims abstract description 53
- 108010073771 Soybean Proteins Proteins 0.000 claims abstract description 37
- 108091005804 Peptidases Proteins 0.000 claims abstract description 36
- 235000013618 yogurt Nutrition 0.000 claims abstract description 30
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 claims abstract description 25
- 229940001941 soy protein Drugs 0.000 claims abstract description 22
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 22
- 239000004365 Protease Substances 0.000 claims abstract description 21
- 235000000346 sugar Nutrition 0.000 claims abstract description 21
- 238000000034 method Methods 0.000 claims abstract description 20
- 238000000227 grinding Methods 0.000 claims abstract description 6
- 238000002791 soaking Methods 0.000 claims abstract description 4
- 230000001954 sterilising effect Effects 0.000 claims abstract description 4
- 239000000203 mixture Substances 0.000 claims description 28
- 239000000243 solution Substances 0.000 claims description 28
- 244000179886 Moringa oleifera Species 0.000 claims description 23
- 235000011347 Moringa oleifera Nutrition 0.000 claims description 23
- 235000013322 soy milk Nutrition 0.000 claims description 19
- 229930091371 Fructose Natural products 0.000 claims description 11
- 239000005715 Fructose Substances 0.000 claims description 11
- 102000035195 Peptidases Human genes 0.000 claims description 11
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 claims description 10
- 229920001542 oligosaccharide Polymers 0.000 claims description 10
- 150000002482 oligosaccharides Chemical class 0.000 claims description 10
- 241001608472 Bifidobacterium longum Species 0.000 claims description 8
- 240000001046 Lactobacillus acidophilus Species 0.000 claims description 8
- 244000199866 Lactobacillus casei Species 0.000 claims description 8
- 241000031670 Saccharopolyspora thermophila Species 0.000 claims description 8
- 235000019629 palatability Nutrition 0.000 claims description 8
- 239000000843 powder Substances 0.000 claims description 7
- 229940024999 proteolytic enzymes for treatment of wounds and ulcers Drugs 0.000 claims description 6
- 238000009835 boiling Methods 0.000 claims description 5
- 230000032683 aging Effects 0.000 claims description 3
- 238000001914 filtration Methods 0.000 claims description 3
- 230000008569 process Effects 0.000 claims description 3
- 238000005057 refrigeration Methods 0.000 claims description 3
- 239000011259 mixed solution Substances 0.000 claims 1
- 238000000855 fermentation Methods 0.000 abstract description 19
- 230000004151 fermentation Effects 0.000 abstract description 19
- 235000019614 sour taste Nutrition 0.000 abstract description 9
- 230000000694 effects Effects 0.000 abstract description 7
- 239000007788 liquid Substances 0.000 abstract description 7
- 241000186660 Lactobacillus Species 0.000 abstract 2
- 229940039696 lactobacillus Drugs 0.000 abstract 2
- 230000005070 ripening Effects 0.000 abstract 1
- 230000000052 comparative effect Effects 0.000 description 27
- 235000019710 soybean protein Nutrition 0.000 description 15
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 10
- 235000018102 proteins Nutrition 0.000 description 7
- 102000004169 proteins and genes Human genes 0.000 description 7
- 108090000623 proteins and genes Proteins 0.000 description 7
- 235000015097 nutrients Nutrition 0.000 description 6
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 5
- 235000012000 cholesterol Nutrition 0.000 description 5
- 239000000796 flavoring agent Substances 0.000 description 5
- 235000019634 flavors Nutrition 0.000 description 5
- 235000013305 food Nutrition 0.000 description 5
- 239000008103 glucose Substances 0.000 description 5
- 150000008163 sugars Chemical class 0.000 description 5
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 4
- 102000004190 Enzymes Human genes 0.000 description 4
- 108090000790 Enzymes Proteins 0.000 description 4
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 4
- 235000015140 cultured milk Nutrition 0.000 description 4
- 229940088598 enzyme Drugs 0.000 description 4
- 230000036541 health Effects 0.000 description 4
- 235000016709 nutrition Nutrition 0.000 description 4
- 230000001953 sensory effect Effects 0.000 description 4
- 238000003860 storage Methods 0.000 description 4
- 206010028980 Neoplasm Diseases 0.000 description 3
- 244000046052 Phaseolus vulgaris Species 0.000 description 3
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 3
- 244000269722 Thea sinensis Species 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 206010012601 diabetes mellitus Diseases 0.000 description 3
- 239000003797 essential amino acid Substances 0.000 description 3
- 235000020776 essential amino acid Nutrition 0.000 description 3
- 239000006210 lotion Substances 0.000 description 3
- 230000035764 nutrition Effects 0.000 description 3
- 230000002265 prevention Effects 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 230000002797 proteolythic effect Effects 0.000 description 3
- 235000013311 vegetables Nutrition 0.000 description 3
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- 208000005718 Stomach Neoplasms Diseases 0.000 description 2
- 229930003427 Vitamin E Natural products 0.000 description 2
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 description 2
- 235000020661 alpha-linolenic acid Nutrition 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 230000000593 degrading effect Effects 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 2
- 206010017758 gastric cancer Diseases 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 229910052742 iron Inorganic materials 0.000 description 2
- 229960004488 linolenic acid Drugs 0.000 description 2
- KQQKGWQCNNTQJW-UHFFFAOYSA-N linolenic acid Natural products CC=CCCC=CCC=CCCCCCCCC(O)=O KQQKGWQCNNTQJW-UHFFFAOYSA-N 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 230000017854 proteolysis Effects 0.000 description 2
- 235000019633 pungent taste Nutrition 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 230000003014 reinforcing effect Effects 0.000 description 2
- 235000012424 soybean oil Nutrition 0.000 description 2
- 239000003549 soybean oil Substances 0.000 description 2
- 201000011549 stomach cancer Diseases 0.000 description 2
- 239000003765 sweetening agent Substances 0.000 description 2
- 235000019165 vitamin E Nutrition 0.000 description 2
- 229940046009 vitamin E Drugs 0.000 description 2
- 239000011709 vitamin E Substances 0.000 description 2
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- 244000291564 Allium cepa Species 0.000 description 1
- 235000002732 Allium cepa var. cepa Nutrition 0.000 description 1
- 240000002234 Allium sativum Species 0.000 description 1
- 235000019737 Animal fat Nutrition 0.000 description 1
- 206010003645 Atopy Diseases 0.000 description 1
- 235000014469 Bacillus subtilis Nutrition 0.000 description 1
- 206010006187 Breast cancer Diseases 0.000 description 1
- 208000026310 Breast neoplasm Diseases 0.000 description 1
- 241000283707 Capra Species 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 206010027304 Menopausal symptoms Diseases 0.000 description 1
- 241000220214 Moringaceae Species 0.000 description 1
- 240000008790 Musa x paradisiaca Species 0.000 description 1
- 240000002778 Neonotonia wightii Species 0.000 description 1
- OBJREHLZEIEGDU-CNJBRALLSA-N Niazirin Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1OC1=CC=C(CC#N)C=C1 OBJREHLZEIEGDU-CNJBRALLSA-N 0.000 description 1
- QSGQMXJNFWYWMM-QOYUQHOESA-N Niazirinin Chemical compound O[C@@H]1[C@H](O)[C@@H](OC(C)=O)[C@H](C)O[C@H]1OC1=CC=C(CC#N)C=C1 QSGQMXJNFWYWMM-QOYUQHOESA-N 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 206010060862 Prostate cancer Diseases 0.000 description 1
- 208000000236 Prostatic Neoplasms Diseases 0.000 description 1
- 244000061456 Solanum tuberosum Species 0.000 description 1
- 235000002595 Solanum tuberosum Nutrition 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003270 Vitamin B Natural products 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 235000021015 bananas Nutrition 0.000 description 1
- 235000013527 bean curd Nutrition 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000004531 blood pressure lowering effect Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 230000003139 buffering effect Effects 0.000 description 1
- 229960005069 calcium Drugs 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 235000013365 dairy product Nutrition 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 235000021245 dietary protein Nutrition 0.000 description 1
- 235000015872 dietary supplement Nutrition 0.000 description 1
- 102000038379 digestive enzymes Human genes 0.000 description 1
- 108091007734 digestive enzymes Proteins 0.000 description 1
- 229940079919 digestives enzyme preparation Drugs 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 235000013601 eggs Nutrition 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 235000021107 fermented food Nutrition 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000012041 food component Nutrition 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- BJHIKXHVCXFQLS-UYFOZJQFSA-N fructose group Chemical group OCC(=O)[C@@H](O)[C@H](O)[C@H](O)CO BJHIKXHVCXFQLS-UYFOZJQFSA-N 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 229930182830 galactose Natural products 0.000 description 1
- 235000004611 garlic Nutrition 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 229930182478 glucoside Natural products 0.000 description 1
- -1 glucoside glycoside Chemical class 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 230000013595 glycosylation Effects 0.000 description 1
- 238000006206 glycosylation reaction Methods 0.000 description 1
- 238000009499 grossing Methods 0.000 description 1
- 235000012907 honey Nutrition 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 230000007413 intestinal health Effects 0.000 description 1
- 229960003284 iron Drugs 0.000 description 1
- CJWQYWQDLBZGPD-UHFFFAOYSA-N isoflavone Natural products C1=C(OC)C(OC)=CC(OC)=C1C1=COC2=C(C=CC(C)(C)O3)C3=C(OC)C=C2C1=O CJWQYWQDLBZGPD-UHFFFAOYSA-N 0.000 description 1
- 150000002515 isoflavone derivatives Chemical class 0.000 description 1
- 235000008696 isoflavones Nutrition 0.000 description 1
- 150000002540 isothiocyanates Chemical class 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 239000011738 major mineral Substances 0.000 description 1
- 235000011963 major mineral Nutrition 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 235000021239 milk protein Nutrition 0.000 description 1
- 235000013384 milk substitute Nutrition 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 230000037125 natural defense Effects 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- OBJREHLZEIEGDU-UHFFFAOYSA-N niazirin Natural products OC1C(O)C(O)C(C)OC1OC1=CC=C(CC#N)C=C1 OBJREHLZEIEGDU-UHFFFAOYSA-N 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 235000012015 potatoes Nutrition 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 239000003531 protein hydrolysate Substances 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 235000013555 soy sauce Nutrition 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 235000021092 sugar substitutes Nutrition 0.000 description 1
- 235000019605 sweet taste sensations Nutrition 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 235000019587 texture Nutrition 0.000 description 1
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 1
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- 230000036642 wellbeing Effects 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
- A23C9/123—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C11/00—Milk substitutes, e.g. coffee whitener compositions
- A23C11/02—Milk substitutes, e.g. coffee whitener compositions containing at least one non-milk component as source of fats or proteins
- A23C11/10—Milk substitutes, e.g. coffee whitener compositions containing at least one non-milk component as source of fats or proteins containing or not lactose but no other milk components as source of fats, carbohydrates or proteins
- A23C11/103—Milk substitutes, e.g. coffee whitener compositions containing at least one non-milk component as source of fats or proteins containing or not lactose but no other milk components as source of fats, carbohydrates or proteins containing only proteins from pulses, oilseeds or nuts, e.g. nut milk
- A23C11/106—Addition of, or treatment with, microorganisms
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/152—Milk preparations; Milk powder or milk powder preparations containing additives
- A23C9/1526—Amino acids; Peptides; Protein hydrolysates; Nucleic acids; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/113—Acidophilus
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/125—Casei
-
- A23Y2220/03—
-
- A23Y2220/17—
Abstract
Description
본 발명은 기호성과 유산균의 생균수를 향상시킨 콩요구르트의 제조방법에 관한 것으로, 상세하게는 두유액에 콩단백질과 당분을 혼합한 후, 혼합유산균과 단백질분해효소를 첨가하여 발효시킴으로써 기호도를 높이고 유산균의 생균수를 향상시킨 콩요구르트의 제조방법에 관한 것이다.The present invention relates to a method for producing soybean yogurt having improved palatability and viable count of lactic acid bacteria. More specifically, soybean protein and sugar are mixed with soybean milk, followed by fermentation by adding mixed lactic acid bacteria and proteolytic enzymes, The present invention relates to a method for producing soybean yogurt having improved viable cell counts of lactic acid bacteria.
대한민국의 웰빙식품을 이끄는 대표주자로서 발효유를 꼽고 있는데, 이는 건강의 핵심요소인 장건강을 개선 또는 유지시키는데 탁월한 효과를 갖기 때문이다. 2016년도의 발효유시장규모는 2조원 내외로 추정되는데, 대부분이 우유를 유산균으로 발효시킨 제품이다. 이러한 우유를 발효시킨 요구르트는 알러지와 아토피 등의 건강상의 사유나, 종교 등의 사유로 인해 유제품을 섭취하기 어려운 사람이 존재하는 데, 이들에게 대체할 수 있는 식품이 식물성 콩요구르트이다. As a representative leader of well-being foods in Korea, we refer to fermented milk because it has an excellent effect in improving or maintaining intestinal health, a key element of health. The market for fermented milk in 2016 is estimated at around W2trn, mostly milk fermented with lactic acid bacteria. Such yogurt fermented milk has difficulty in eating dairy products due to health reasons such as allergies and atopy, religion, etc., and vegetable soy yogurt is a substitute food.
콩요구르트에 사용되는 대두는 우리나라에서는 오래전부터 두부, 된장, 콩 간장 등 여러 형태의 음식과 영양식으로 사용되어 왔으며, 필수 아미노산이 고루 함유되어 있는 양질의 단백질원으로 우유나 계란과 비교해도 거의 대등할 만큼 영양이 풍부하다. 대두에는 그 종류에 상관없이 40% 가량을 차지하는 단백질에는 필수 아미노산이 균형 있게 배합되어 있으며 다른 식품성 단백질에는 부족 되기 쉬운 리신이 많은 것이 특징이다. 지방 함유량은 18% 정도인데, 대부분이 불포화지방산이며 50% 이상이 최상급의 리놀렌산이다. 또 리놀렌산의 작용을 돕는 비타민 E도 충분하여 동물성 지방의 과잉섭취로 인한 콜레스테롤을 제거하는 역할도 한다. 그 외에 비타민 B가 풍부하여 피로회복을 도우며, 칼슘, 철분 등의 영양성분도 풍부하다. 이 밖에도 대두에 함유되어 있는 이소플라본(isoflavon)은 유방암이나 전립선암과 같은 호르몬 관련 암에 대해서 강한 항암효과를 가지고 있는 것으로 알려져 있으며, 여성의 갱년기 증상을 완화시켜주는 효과도 있는 것으로 밝혀지고 있다. 대두에 함유되어 있는 레시틴 (lecithin)이나 사포닌 (saponin)등은 체내 콜레스테롤 농도를 낮추어 줌으로써 각종 성인병을 예방하는 효과가 있으며, 이 밖에도 대두에는 각종 암과 성인병을 예방하여 주는 여러 가지 성분이 함유되어 있는 것으로 밝혀지고 있다.Soybeans used in soy yogurt have been used in many forms of food and nutrition in Korea for a long time, such as tofu, soybean paste, bean soy sauce, etc. It is a high quality protein source containing essential amino acids and is almost comparable to milk or eggs It is rich in nutrition. Regardless of the type of soybeans, about 40% of the protein contains a balanced mix of essential amino acids and is characterized by many lysine is likely to be missing in other food proteins. The fat content is about 18%, mostly unsaturated fatty acids, and over 50% is the highest grade linolenic acid. In addition, vitamin E helps the action of linolenic acid is sufficient to remove cholesterol from excessive intake of animal fat. In addition, it is rich in vitamin B, helps to recover fatigue, and is rich in nutrients such as calcium and iron. In addition, isoflavones, which are contained in soybeans, are known to have strong anticancer effects against hormone-related cancers such as breast cancer and prostate cancer, and have been shown to alleviate women's menopausal symptoms. Lecithin and saponin contained in soybeans are effective in preventing various adult diseases by lowering the concentration of cholesterol in the body. In addition, soybean contains various components that prevent various cancers and adult diseases .
그러나 콩요구르트는 위에서 언급한 콩이 갖고 있는 많은 장점에도 불구하고 우유로 만든 요구르트에 비하여 특유의 비린 맛으로 인하여 관능적으로 맛이 매우 떨어지며, 콩을 원료로 하여 발효하였을 때 두유처럼 고소한 맛이 나지 않고 시큼한 맛이 강하여 상한 것으로 인식하기 쉬운 문제점이 있어 1980년대부터 학계에서 연구해왔지만 30년 넘게 상품화되기 어려웠다. 콩요구르트로서 국내에 출시된 제품들은 정식품의 제품으로부터 시작하여 타 제품들이 공통적으로 우유로 만든 요구르트에 비하여 식물성 원료가 들어가 있다는 차별성을 제외하고는 관능적인 관점에서 여전히 기호성이 떨어지는 문제가 있었고, 이로 인하여 소비자에게 대중화되지 못하는 아쉬움이 있었다.However, despite the many advantages of soybeans mentioned above, soybean yogurt has a distinctive sensory taste due to its pungent taste compared to milk yogurt. When fermented with soybean as a raw material, it does not taste like soy milk There is a problem that it is easy to recognize that it is difficult to recognize because it is strong in sour taste. It has been studied in the academic world since the 1980s, but it has been difficult to commercialize it for over 30 years. As the soybean yogurt, the products launched in the domestic market have a problem in that the taste is still poor in terms of sensuality except for the difference that the yogurt made from the regular product and the other products have the common vegetable raw material in comparison with the milk yogurt. There was a pity that it was not popularized by consumers.
이에 본 발명자는 이를 극복하여 콩고유의 맛을 가지면서도 기호성을 향상시키는 동시에 유산균발효가 매우 우수하게 이루어지는 기술적 방안을 확립함으로써 우유 대체 발효식품이 필요한 사람들에게 큰 유익이 될 뿐만 아니라 우유로 만든 요구르트와 비교하여 콩고유의 맛과 차별성을 갖춘 식물성 콩요구르트를 완성하게 되었다. Accordingly, the present inventors have overcome the above problems and have found that by improving the tastes of the Congo flavor while improving the palatability and establishing a technological way of fermenting lactic acid bacteria, the fermented milk of the present invention is advantageous to those who need milk substitute fermented food, So that the vegetable soy yoghurt having the flavor and differentiability of the Congolese oil was completed.
본 발명의 목적은 콩 고유의 고소한 맛을 가지면서도 콩이 가지는 특유의 비린 맛을 상쇄시켜 기호성을 향상시키는 동시에 유산균발효가 우수하여 유산균 생균수를 향상시킨 콩요구르트를 제공하는 것이다.An object of the present invention is to provide a soybean yogurt having an excellent taste inherent to soybeans and improving the palatability of the soybeans by canceling the peculiar pungency of the soybeans and improving the fermentation of lactic acid bacteria and thereby improving the number of lactic acid bacteria.
상기 목적을 달성하기 위한 본 발명의 기호성과 유산균의 생균수를 향상시킨 콩요구르트의 제조방법은, To achieve the above object, there is provided a method for producing soybean yogurt having improved palatability and viable cell count of lactic acid bacteria,
대두를 1~3시간 동안 실온에서 물에 불리는 1단계;Soybeans are firstly called water at room temperature for 1 to 3 hours;
상기 1단계에서 불려진 대두를 80~100℃의 물에 10~20분 동안 침지하는 2단계;A step of soaking the so-called step 1 in water at 80 to 100 ° C for 10 to 20 minutes;
상기 2단계에서 침지한 대두를 탈피하는 3단계;A step 3 for removing the soybean soaked in the step 2;
상기 3단계에서 탈피한 대두에 대두 부피의 5~8배의 물을 넣고 마쇄하는 4단계;Step 4 is a step of putting 5 to 8 times as much water as soybeans in the soybeans soaked in the step 3 and grinding them;
상기 4단계에서 마쇄된 대두를 100~170메쉬의 필터로 여과하여 8~10Brix의 두유액을 수득하는 5단계;Filtering the soybeans ground in step 4 with a filter having a size of 100 to 170 mesh to obtain a soy milk solution having a boiling point of 8 to 10 Brix;
상기 5단계에서 수득된 두유액에 두유액 100중량부에 대하여 콩단백질(Isolated soy protein) 0.5~3중량부와 당분 5~12중량부를 첨가하여 두유혼합액을 수득하는 6단계;0.5 to 3 parts by weight of isolated soy protein and 5 to 12 parts by weight of sugar are added to the soybean milk obtained in the
상기 6단계에서 수득한 두유혼합액을 살균하는 7단계;
상기 살균된 두유혼합액에 혼합유산균과 단백분해효소를 첨가하여 pH 4.2~4.6이 되도록 발효시키는 8단계; 및 Adding lactic acid bacteria and proteolytic enzymes to the sterilized soybean milk mixture to ferment at a pH of 4.2 to 4.6; And
상기 발효된 두유혼합액을 0~10℃의 냉장 온도에서 12~24시간 동안 숙성시키는 9단계를 포함하는 것을 특징으로 한다.And aging the fermented soybean milk mixture at a refrigeration temperature of 0 to 10 ° C for 12 to 24 hours.
상기 4단계의 공정에서 탈피한 대두에 탈피한 대두 100중량부를 기준으로 모링가분말 0.5~5중량부를 첨가하여 함께 마쇄하는 공정을 추가할 수 있다. Adding 0.5 to 5 parts by weight of Moringa powder to 100 parts by weight of the soybean which has been melted in the step of the step 4, and grinding together.
상기 당분은 올리고당과 과당을 1:0.5~1.5의 중량비로 혼합한 것을 특징으로 한다.The sugar is characterized in that the oligosaccharide and fructose are mixed at a weight ratio of 1: 0.5 to 1.5.
상기 혼합유산균은 L. casei , B. longum , L. acidophilus, 및 S. thermophilus의 균주가 하나 이상 혼합된 것을 특징으로 한다. The mixed lactic acid bacteria are characterized in that one or more strains of L. casei , B. longum , L. acidophilus, and S. thermophilus are mixed.
상기 혼합유산균의 함량은 두유혼합액의 0.005~0.01중량%인 것을 특징으로 한다. The content of the mixed lactic acid bacteria is 0.005 to 0.01% by weight of the soy milk mixture.
상기 단백분해효소는 Protamex 또는 Flavouzyme 인 것을 특징으로 한다. Wherein the protease is Protamex or Flavouzyme.
상기 단백분해효소의 함량은 두유혼합액의 0.01~0.05중량%인 것을 특징으로 한다. The content of the proteolytic enzyme is 0.01 to 0.05% by weight of the soybean milk mixture.
본 발명의 콩요구르트는 두유액에 콩단백질을 보강함으로써 발효로 인한 신맛을 보정하는 효과를 가지며, 유동성 조직감을 개선시킬 뿐 아니라 혼합유산균과 함께 단백분해효소로 발효시킴으로써 발효과정에서 콩단백질이 아미노산으로 분해되어 아미노산 특유의 감칠맛을 느끼게 함으로써 기호도를 높이는 효과가 있다. The soybean yogurt of the present invention has an effect of correcting sour taste due to fermentation by reinforcing soybean protein in soybean milk. It not only improves flow texture but also fermented with protease in combination with mixed lactic acid bacteria, It has the effect of increasing the preference degree by making the amino acid-specific flavor feel.
본 발명의 콩요구르트는 두유액에 콩단백질을 보강함으로써 발효과정에서 완충력(Buffer capacity)을 높여서 유산균의 생균수를 크게 향상시킬 수 있으며 사멸율도 줄이는 효과가 있다. The soybean yogurt of the present invention enhances the buffer capacity in the fermentation process by reinforcing the soybean protein in the soy milk solution, thereby greatly increasing the viable cell count of the lactic acid bacteria and decreasing the mortality rate.
본 발명의 콩요구르트는 두유액 제조 과정에 모링가분말을 첨가함으로써 영양성분을 강화하고, 발효과정에서 완충작용을 도와 유산균의 증식을 향상시키는 효과가 있다.The soybean yogurt of the present invention has the effect of enhancing the nutritional composition by adding moringa powder to the soy milk solution preparation process and enhancing the growth of lactic acid bacteria by buffering the fermentation process.
도 1은 본 발명의 콩요구르트의 제조공정도를 도시한 것이다.
도 2는 단백질분해효소의 첨가유무에 따른 유산균 생균수를 나타낸 그래프이다.BRIEF DESCRIPTION OF THE DRAWINGS Fig. 1 shows a process for producing soybean yogurt according to the present invention.
Fig. 2 is a graph showing the number of lactic acid bacteria living cells according to the presence or absence of protease.
본 발명을 실시하기 위한 구체적인 내용은 다음과 같다. Specific details for carrying out the present invention are as follows.
대두를 1~3시간 동안 실온에서 물에 불리는 1단계; 상기 1단계에서 불려진 대두를 80~100℃의 물에 10~20분 동안 침지하는 2단계; 상기 2단계에서 침지한 대두를 탈피하는 3단계; 상기 3단계에서 탈피한 대두에 대두 부피의 5~8배의 물을 넣고 마쇄하는 4단계; 상기 4단계에서 마쇄된 대두를 100~170메쉬의 필터로 여과하여 8~10Brix의 두유액을 수득하는 5단계; 상기 5단계에서 수득된 두유액에 두유액 100중량부에 대하여 콩단백질(Isolated soy protein) 0.5~3중량부와 당분 5~12중량부를 첨가하여 두유혼합액을 수득하는 6단계; 상기 6단계에서 수득한 두유혼합액을 살균하는 7단계; 상기 살균된 두유혼합액에 혼합유산균과 단백분해효소를 첨가하여 pH 4.2~4.6이 되도록 발효시키는 8단계; 및 상기 발효된 두유혼합액을 0~10℃의 냉장 온도에서 12~24시간 동안 숙성시키는 9단계를 포함하는 것을 특징으로 한다.Soybeans are firstly called water at room temperature for 1 to 3 hours; A step of soaking the so-called step 1 in water at 80 to 100 ° C for 10 to 20 minutes; A step 3 for removing the soybean soaked in the step 2; Step 4 is a step of putting 5 to 8 times as much water as soybeans in the soybeans soaked in the step 3 and grinding them; Filtering the soybeans ground in step 4 with a filter having a size of 100 to 170 mesh to obtain a soy milk solution having a boiling point of 8 to 10 Brix; 0.5 to 3 parts by weight of isolated soy protein and 5 to 12 parts by weight of sugar are added to the soybean milk obtained in the
상기 2단계의 공정에서 불려진 대두를 80~100℃의 물에 10~20분 동안 침지하는데, 이렇게 뜨거운 물에 침지하면 콩의 탈피를 쉽게하며, 콩에 함유된 소화흡수를 방해하는 효소를 불활성화할 수 있으며, 콩이 가지는 특유의 비린내를 약화시킬 수 있다. The soybean called in the step 2 is immersed in water at 80 to 100 ° C. for 10 to 20 minutes. When the soybean is soaked in hot water, the soybean is easily peeled off and the enzyme which inhibits digestion and absorption contained in the soybean is inactivated And it can attenuate the specific fishy smell of beans.
상기 4단계의 공정에서 탈피한 대두에 탈피한 대두 100중량부를 기준으로 모링가분말 0.5~5중량부를 첨가하여 함께 마쇄하는 공정을 추가할 수 있다.Adding 0.5 to 5 parts by weight of Moringa powder to 100 parts by weight of the soybean which has been melted in the step of the step 4, and grinding together.
모링가는(Moringa Oleifera)는 십자화목 모링가과(Moringaceae)에 속하며 열대 및 아열대 기후 지역에 분포하는 다년생의 콩과 식물로서 5~12m에 이르는 속성교목으로, 나뭇잎과 열매뿐만 아니라 뿌리까지 나무 전체를 식용으로 하는 열대성 나무로 인도 서북부가 원산지이다. 모링가는 비타민 16종, 미네랄 17종, 필수 아미노산 9종을 포함한 아미노산 20종, 지방산 15종, 오메가 3,6,9 등 90여 가지 이상의 영양소를 포함하고 있어 2000년 11월 21일자 디스커버리 채널에서는 세상에서 영양소가 가장 풍부한 식물로 인체에 필요한 90여 가지 이상의 영양소가 함유되어 있어 "기적의 나무(Miracle Tree)"라고 보도하기도 하였다. Moringa Oleifera is a perennial soybean plant in the Moringaceae family, which is distributed in tropical and subtropical climatic regions. It is an important arboreous tree ranging from 5 to 12 meters in length. It is native to the northwestern part of India. Mouring contains more than 90 nutrients including 16 vitamins, 17 minerals, 20 essential amino acids, 15 fatty acids, and 3, 6, and 9 omega. Is the most abundant nutrient in the world, containing more than 90 nutrients needed for the human body, "Miracle Tree" was also reported.
이러한 모링가는 콜레스테롤 예방, 항염증, 시력 개선, 고혈압, 면역 강화, 항산화로 노화방지, 종양 예방, 당뇨 등 많은 효능을 가지고 있는 것으로 알려져 있고, 특히 모링가 잎은 단백질, 칼슘, 철, 베타카로틴(비타민 A의 전구체), 비타민 C와 비타민 E가 매우 풍부하며, 나아지린(niazirin), 니아지리닌(niazirinin), 이소티오시아네이트(isothiocyanate) 등의 플라보노이드 성분 및 글루코사이드 배당체 성분이 함유되어 있어 항산화 작용을 통해 활성산소를 제거하며, 면역체계를 강화시키며, 혈관의 중성지질을 분해하는 기능이 탁월하여 지방 침착을 막아 혈액순환을 원활하게 함으로써 혈압 강하 효과가 있으며, 혈관 속 노폐물이나 불필요한 찌꺼기들을 흡착하고 배출하는 역할을 하므로 혈청의 지질과, 혈당, 콜레스테롤을 낮추어주며, 비만에도 효과가 있는 것으로 알려져 있다. 또한, 여러 유효성분에 의해 신체의 자연 방어 증가, 눈과 뇌에 영양 제공, 신진대사 증진, 세포구조 증진, 주름개선, 간 및 신장의 정상기능 부여, 소화작용, 항염증작용, 혈당조적 작용 등 그 효용 가치를 인정받고 있다. It is known that Moringa has many effects such as prevention of cholesterol, anti-inflammation, improvement of eyesight, hypertension, immunity enhancement, antioxidation, anti-aging, tumor prevention and diabetes. In particular, Moringa leaf is known to have various effects such as protein, calcium, iron, Vitamin A and vitamin E, and flavonoid components such as niazirin, niazirinin, and isothiocyanate, and glucoside glycoside components, It is effective to remove active oxygen through strengthening the immune system and to break down the neutral lipid of the blood vessels, thereby preventing the fat deposition and smoothing the blood circulation. Thus, it has a blood pressure lowering effect and adsorbs the vascular waste or unnecessary debris It helps to lower serum lipids, blood sugar, and cholesterol, and is also effective in obesity. It is known to. In addition, various active ingredients can increase the body's natural defense, provide nutrition to the eyes and brain, promote metabolism, improve cell structure, improve wrinkles, normal function of liver and kidney, digestion, anti-inflammation, Its utility value is recognized.
상기 4단계의 공정에 모링가분말을 첨가하여 함께 마쇄할 경우, 두유액에 모링가의 영양성분이 잘 분산되어 유산균 발효과정에서 완충작용을 하여 유산균의 증식으로 인해 산도가 급격하게 낮아지는 것을 방지하는 역할을 하며, 유산균의 증식에도 도움이 된다. 또한 모링가에 풍부하게 함유된 영양성분을 함께 섭취할 수 있어 영양보충 면에서도 좋다.When the moringa powder is added to the process of step 4 above, the nutritional components of the moringa are well dispersed in the soybean milk to buffer the lactic acid bacteria fermentation process, thereby preventing the acidity from being drastically lowered due to the growth of the lactic acid bacteria And it also helps in the proliferation of lactic acid bacteria. In addition, Moringa rich in nutrients can be taken together with nutritional supplement is also good.
상기 6단계의 공정에서 두유액에 콩단백질(Isolated soy protein)을 첨가하여 보강함으로써 이후의 발효 과정에서 유산균의 증식에 의한 신맛을 상쇄하여 보정하는 효과가 있으며, 두유액과 콩단백질의 혼합액을 유산균으로 발효시키면 새콤한 발효취는 나지만 콩의 깊은 맛을 느끼지 못하였는데, 혼합유산균과 함께 단백분해효소로 분해시킬 경우, 콩단백질이 분해되어 생성되는 펩타이느와 아미노산으로 인한 고소한 감칠맛의 깊은 맛을 느끼게 할 수 있어 기호도를 향상시키며, 두유액의 완충력(Buffer capacity)을 높여서 유산균의 생균수를 크게 향상시킬 수 있으며 사멸율도 줄이는 효과가 있다. In the step 6, soybean protein is added to soybean milk to reinforce the soybean milk, thereby correcting the sour taste due to the fermentation of the lactic acid bacteria in the subsequent fermentation process. The mixture of soybean milk and soybean protein is mixed with lactic acid bacteria , It is sour fermentation but it does not feel the deep taste of soybean. When it is decomposed with proteolytic enzyme together with mixed lactic acid bacteria, soybean protein is decomposed and peptiche is produced, and the deep flavor And it is possible to improve the preference degree and to increase the buffer capacity of the soy milk solution, thereby greatly increasing the number of viable cells of the lactic acid bacteria and decreasing the mortality rate.
상기 콩단백질은 두유액 100중량부에 대하여 0.5~3중량부를 첨가하여 단백질의 농도를 20~40%로 조정하는 것이 바람직한데, 상기 범위를 초과할 경우, 죽과 같이 점성이 증가하면서 기호성이 오히려 떨어지므로 바람직하지 않으며, 상기 범위 미만일 경우, 발효과정에서의 신맛을 상쇄시키지 못하므로 신맛이 강해져 바람직하지 않다. The soy protein is preferably adjusted to a protein concentration of 20 to 40% by adding 0.5 to 3 parts by weight based on 100 parts by weight of the soybean milk. When the soy protein is over the above range, viscosity increases, And if it is less than the above range, the sour taste in the fermentation process can not be canceled, so that the sour taste is undesirably increased.
상기 당분은 올리고당과 과당을 1:0.5~1.5의 중량비로 혼합한 것을 특징으로 한다.The sugar is characterized in that the oligosaccharide and fructose are mixed at a weight ratio of 1: 0.5 to 1.5.
올리고당(oligosaccharides)은 글루코스(glucose), 프룩토스(fructose), 갈락토스(galactose)와 같은 당(糖)이 2∼8개 정도 결합한 당으로 감미를 가진 수용성의 결정성 물질로서 기존의 감미료인 설탕, 맥아당 등이 가진 건강상의 결점을 개선할 목적으로 효소 합성에 의해 만들어진 당으로 구성된 물질이다. 올리고당은 설탕과 물리적인 특성이 매우 비슷하고, 순수한 올리고당의 감미도는 설탕의 20∼40% 정도의 감미도 있기 때문에 설탕 대체물질로서 사용되고 있으나, 장내 소화 효소에 의하여 분해되지 않고 칼로리가 낮은 면에서 설탕과 생리적인 특성이 다르며, 특히 콜레스테롤 상태 개선, 항균 작용, 면역력 증강 등 신체의 건강에 매우 유익한 점이 과학적으로 증명되고 있다. 올리고당은 콩, 양파, 마늘, 바나나, 감자 등 자연상태의 어떤 식물에나 소량 함유되어 있으므로 충분한 양을 섭취하는 것이 어려워 공업적으로 효소를 이용하여 대량 생산한다.Oligosaccharides are oligosaccharides which are sugar-soluble sugars having about 2 to 8 sugars, such as glucose, fructose and galactose. They are sugar, It is a substance composed of sugars made by enzymatic synthesis for the purpose of improving the health defects of maltose and the like. Oligosaccharides are very similar in physical properties to sugars and pure oligosaccharides are used as sugar substitutes because they have a sweetness of about 20 to 40% of sugar. However, they are not degraded by intestinal digestive enzymes, Physiological characteristics are different, and it is scientifically proven that the cholesterol state improvement, the antibacterial activity, the immunity enhancement, and the like are very beneficial to the health of the body. Oligosaccharides are contained in a small amount in any natural plant such as beans, onions, garlic, bananas, and potatoes, so it is difficult to ingest a sufficient amount.
과당은 육탄당의 하나로 무색의 흡습성을 가지며, 식물계에 널리 존재한다. 특히 포도당과 함께 과일 속에 유리 형태로 들어 있거나, 포도당과 결합하여 슈크로스로서 함유되어 있다. 벌꿀의 액상부의 대부분이 과당이며, 과즙에서 분리되어진다. 과당은 생물의 당대사(糖代謝)에서 중요한 역할을 하는데, 포도당이 분해되는 경우나 글리코젠으로 합성되는 경우 등은 모두 과당을 거친다. 과당은 당류 중에서 단맛이 가장 강하나, 가열하면 3분의 1로 약해진다. 또한 과당은 포도당을 이용하지 못하는 당뇨병 환자용 감미료, 쇠약자나 어린이의 영양제 외에 해독·강심·이뇨제로 사용되며, 습성을 이용하여 카스텔라·스펀지케이크 등이 마르는 것을 방지하기 위해 사용되기도 한다.Fructose is one of the major minerals that have colorless hygroscopicity and is widely found in the plant kingdom. It is contained in the form of glass in the fruit together with glucose, or it is contained as sucrose in combination with glucose. Most of the liquid part of honey is fructose, and it is separated from juice. Fructose plays an important role in the metabolism of sugar in the living organism, such as when glucose is degraded or when it is synthesized by glycosylation. Fructose is the strongest sweetness in sugars, but it weakens by one-third when heated. Fructose is also used as a detoxifying, diabetic, diuretic in addition to diabetic sweeteners, weakeners and children's nutrients that can not use glucose, and it is also used to prevent the drying of the castella, sponge cake, etc. by using the habit.
상기 올리고당과 과당은 본 발명의 콩요구르트에 단맛을 부여할 뿐만 아니라, 발효과정에서 유산균의 먹이로 이용되어 유산균의 증식을 향상시키는 역할을 한다. The oligosaccharide and fructose not only impart sweetness to the soybean yogurt of the present invention but also serve as a food for lactic acid bacteria in the fermentation process and improve the growth of lactic acid bacteria.
상기 당분은 두유액 100중량부를 기준으로 5~12중량부를 첨가하는 것이 바람직한데, 상기 범위를 초과할 경우, 단맛이 지나치게 강해져 바람직하지 않으며, 상기 범위 미만일 경우, 맛이 좋지 않아 기호도가 떨어져 바람직하지 않다.It is preferable that 5 to 12 parts by weight of the sugar is added based on 100 parts by weight of the soy milk solution. If the sugar content exceeds the above range, the sweet taste becomes too strong and undesirable. When the sugar content is less than the above range, not.
상기 혼합유산균은 L. casei , B. longum , L. acidophilus, 및 S. thermophilus의 균주가 하나 이상 혼합된 것을 특징으로 한다. The mixed lactic acid bacteria are characterized in that one or more strains of L. casei , B. longum , L. acidophilus, and S. thermophilus are mixed.
상기 혼합유산균의 함량은 두유혼합액의 0.005~0.01중량%인 것이 바람직한데, 상기 범위를 초과할 경우, 초과 첨가량에 비해 발효결과가 현저하게 향상되지 않아 효율이 떨어지며, 상기 범위 미만일 경우, 오염의 우려가 있어서 바람직하지 않다. The content of the mixed lactic acid bacteria is preferably 0.005 to 0.01% by weight based on the total weight of the soybean milk mixture. If the content exceeds the above range, the fermentation result is not remarkably improved as compared with the excess amount and the efficiency is lowered. Which is undesirable.
상기 단백분해효소는 Protamex, Flavouzyme 또는 이들의 혼합효소인 것을 특징으로 한다. Wherein the protease is Protamex, Flavouzyme or a mixed enzyme thereof.
단백질분해효소인 Protamex와 Flavouzyme은 정제된 효소가 아니라 단백질분해에 적합하도록 미생물배양을 통해 생산된 효소로서 분말 고형상의 시판 효소제제이며, 단백질 가수분해물 또는 식품제조에 널리 사용된다. 특히 Protamex는 pH 7~9의 조건에서, Flavouzyme은 pH 6~7의 조건에서 가장 강한 단백질분해능을 가지며, 가수분해물의 맛과 향기를 개선하는 역할을 한다.Protease enzymes Protamex and Flavouzyme are not purified enzymes but enzymes produced by culturing microorganisms suitable for protein degradation. They are powdery solid form commercial enzyme preparations and widely used for protein hydrolyzate or food production. In particular, Protamex has the strongest proteolytic activity at pH 7-9 and Flavouzyme has the strongest proteolytic activity at pH 6 ~ 7 and improves the taste and aroma of the hydrolyzate.
상기 단백분해효소의 함량은 두유혼합액의 0.01~0.05중량%인 것이 바람직한데, 상기 범위를 초과할 경우 과도한 단백질분해에 의해 쓴맛이 날 수 있어 바람직하지 않으며, 상기 범위 미만일 경우, 단백질분해능이 낮아져 맛이 없어 기호도가 떨어지므로 바람직하지 않다.The content of the proteolytic enzyme is preferably 0.01 to 0.05% by weight of the soybean milk mixture. If it exceeds the above range, the protein may degrade due to excessive proteolytic degradation, which is undesirable. There is no preference because the degree of preference decreases.
이하, 본 발명의 이해를 돕기 위하여 실시예 등을 들어 상세하게 설명하기로 한다. 그러나, 본 발명에 따른 실시예들은 여러 가지 다른 형태로 변형될 수 있으며, 본 발명의 범위가 하기 실시예들에 한정되는 것은 아니다. Hereinafter, embodiments of the present invention will be described in detail to facilitate understanding of the present invention. However, the embodiments according to the present invention can be modified in various other forms, and the scope of the present invention is not limited to the following embodiments.
<실시예 1>≪ Example 1 >
대두 5kg을 물에 2시간 동안 물에 불린 다음 100℃의 끓는 물에 15분간 침지한 후, 불려진 대두의 껍질을 벗기고, 껍질을 벗긴 대두 5kg에 30리터의 물을 첨가하여 120~150메쉬로 마쇄하였다. 상기 마쇄된 대두를 150메쉬의 필터로 여과하여 8.5 Brix의 두유액을 수득하였다. 상기 수득된 두유액 1kg에 콩단백질 5g과 올리고당과 과당이 1:1의 중량비로 혼합된 당분을 100g을 첨가여 두유혼합액을 수득하였으며, 이 두유혼합액은 60~80℃에서 30분간 살균처리하였다. 살균처리된 두유혼합액 100ml에 L. casei , B. longum, L. acidophilus, 및 S. thermophilus의 균주가 혼합된 배양액을 20㎕로 접종하고, 단백질분해효소 Protamex와 Flavouzyme를 1:1의 중량비로 혼합하여 30㎍ 첨가하여 36℃의 항온기에서 1일 동안 발효시켰다.5 kg of soybeans were soaked in water for 2 hours in water and then immersed in boiling water at 100 ° C. for 15 minutes. Then the peeled soybean skin was peeled off, and 30 liters of water was added to 5 kg of peeled soybeans, Respectively. The ground soybeans were filtered through a filter of 150 mesh to obtain a soybean milk solution of 8.5 Brix. To 1 kg of soy milk thus obtained, 5 g of soybean protein, 100 g of sugar mixed with oligosaccharide and fructose at a weight ratio of 1: 1 was added to obtain a soybean milk mixture, which was sterilized at 60 to 80 ° C for 30 minutes. 20 μl of a culture solution in which L. casei , B. longum, L. acidophilus, and S. thermophilus strains were mixed was inoculated in 100 ml of a sterilized soybean milk mixture , and Protease protease and Flavouzyme were mixed at a weight ratio of 1: 1 And the mixture was fermented in a thermostat at 36 DEG C for 1 day.
<실시예 2>≪ Example 2 >
수득된 두유액 1kg에 콩단백질 10g을 첨가하는 것을 제외하고는 상기 실시예 1과 동일하게 제조하였다. The procedure of Example 1 was repeated except that 10 g of soybean protein was added to 1 kg of soybean milk obtained.
<실시예 3>≪ Example 3 >
수득된 두유액 1kg에 콩단백질 20g을 첨가하는 것을 제외하고는 상기 실시예 1과 동일하게 제조하였다. The procedure of Example 1 was repeated except that 20 g of soybean protein was added to 1 kg of soybean milk obtained.
<실시예 4><Example 4>
수득된 두유액 1kg에 콩단백질 30g을 첨가하는 것을 제외하고는 상기 실시예 1과 동일하게 제조하였다. The procedure of Example 1 was repeated except that 30 g of soybean protein was added to 1 kg of soy milk obtained.
<실시예 5>≪ Example 5 >
대두 5kg을 물에 2시간 동안 물에 불린 다음 100℃의 끓는 물에 15분간 침지한 후, 불려진 대두의 껍질을 벗기고, 껍질을 벗긴 대두 5kg에 모링가분말 100g과 30리터의 물을 첨가하여 120~150메쉬로 마쇄하였다. 상기 마쇄된 모링가혼합대두를 150메쉬의 필터로 여과하여 8.5 Brix의 모링가두유액을 수득한 것을 제외하고는 실시예 1과 동일하게 제조하였다. 5 kg of soybeans were soaked in water for 2 hours in water and then immersed in boiling water at 100 ° C. for 15 minutes. The soybeans were then peeled off and 100 g of moringa powder and 30 liters of water were added to 5 kg of peeled soybeans To 150 mesh. The milled Moringa mixed soybean was filtered through a filter of 150 mesh to prepare a Moring goat milky lotion of 8.5 Brix.
<실시예 6>≪ Example 6 >
수득된 모링가두유액 1kg에 콩단백질 10g을 첨가하는 것을 제외하고는 상기 실시예 5와 동일하게 제조하였다. The procedure of Example 5 was repeated except that 10 g of soybean protein was added to 1 kg of the obtained Moring tea milk.
<실시예 7>≪ Example 7 >
수득된 모링가두유액 1kg에 콩단백질 20g을 첨가하는 것을 제외하고는 상기 실시예 5와 동일하게 제조하였다. The same procedure as in Example 5 was conducted except that 20 g of soybean protein was added to 1 kg of the obtained Moring tea milk.
<실시예 8>≪ Example 8 >
수득된 모링가두유액 1kg에 콩단백질 30g을 첨가하는 것을 제외하고는 상기 실시예 5와 동일하게 제조하였다. The same procedure as in Example 5 was conducted except that 30 g of soybean protein was added to 1 kg of the obtained Moring tea milk.
<비교예 1>≪ Comparative Example 1 &
수득된 두유액 1kg을 60~80℃에서 30분간 살균처리하고, 살균처리된 두유혼합액 100ml에 L. casei , B. longum , L. acidophilus, 및 S. thermophilus의 균주가 혼합된 배양액을 20㎕로 접종한 다음 36℃의 항온기에서 1일 동안 발효시켰다.1 kg of the obtained soybean milk was sterilized at 60 to 80 ° C. for 30 minutes , and 20 μl of a culture solution in which L. casei , B. longum , L. acidophilus, and S. thermophilus strains were mixed with 100 ml of a sterilized soybean milk mixture After inoculation, they were fermented in a thermostat at 36 ° C for 1 day.
<비교예 2>≪ Comparative Example 2 &
수득된 모링가두유액 1kg을 60~80℃에서 30분간 살균처리하고, 살균처리된 모링가두유액 100ml에 L. casei , B. longum , L. acidophilus, 및 S. thermophilus의 균주가 혼합된 배양액을 20㎕로 접종한 다음 36℃의 항온기에서 1일 동안 발효시켰다. 1 kg of the obtained Mouring Milk Milk was sterilized at 60 to 80 ° C for 30 minutes , and a culture solution in which L. casei , B. longum , L. acidophilus, and S. thermophilus strains were mixed with 100 ml of the sterilized Mulling Milk Milk Solution was added to 20 Lt; / RTI > and then fermented in a thermostat at 36 DEG C for 1 day.
<비교예 3>≪ Comparative Example 3 &
수득된 두유액 1kg을 60~80℃에서 30분간 살균처리하고, 살균처리된 두유혼합액 100ml에 L. casei , B. longum , L. acidophilus, 및 S. thermophilus의 균주가 혼합된 배양액을 20㎕로 접종하고, 단백질분해효소 Protamex와 Flavouzyme를 1:1의 중량비로 혼합하여 30㎍ 첨가하여 36℃의 항온기에서 1일 동안 발효시켰다.1 kg of the obtained soybean milk was sterilized at 60 to 80 ° C. for 30 minutes , and 20 μl of a culture solution in which L. casei , B. longum , L. acidophilus, and S. thermophilus strains were mixed with 100 ml of a sterilized soybean milk mixture And protease enzymes Protamex and Flavouzyme were mixed at a weight ratio of 1: 1, and 30 μg of the protease was added thereto, followed by fermentation in a thermostat at 36 ° C for 1 day.
<비교예 4>≪ Comparative Example 4 &
수득된 모링가두유액 1kg을 60~80℃에서 30분간 살균처리하고, 살균처리된 모링가두유액 100ml에 L. casei , B. longum , L. acidophilus, 및 S. thermophilus의 균주가 혼합된 배양액을 20㎕로 접종하고, 단백질분해효소 Protamex와 Flavouzyme를 1:1의 중량비로 혼합하여 30㎍ 첨가하여 36℃의 항온기에서 1일 동안 발효시켰다.1 kg of the obtained Mouring Milk Milk was sterilized at 60 to 80 ° C for 30 minutes , and a culture solution in which L. casei , B. longum , L. acidophilus, and S. thermophilus strains were mixed with 100 ml of the sterilized Mulling Milk Milk Solution was added to 20 Mu l, and protease enzymes Protamex and Flavouzyme were mixed at a weight ratio of 1: 1, and 30 [micro] g was added thereto, followed by fermentation in a thermostat at 36 [deg.] C for 1 day.
<비교예 5>≪ Comparative Example 5 &
수득된 두유액 1kg에 콩단백질 20g을 첨가하되, 단백질분해효소를 첨가하지 않은 것을 제외하고는 실시예 3과 동일하게 제조하였다.20 g of soybean protein was added to 1 kg of soybean milk obtained, and the same procedure as in Example 3 was carried out except that no proteolytic enzyme was added.
<시험예 1> 기호성에 대한 관능테스트<Test Example 1> Sensory test on palatability
본 발명의 실시예 1 내지 8 및 비교예 1 내지 4의 콩요구르트에 대하여 20~40대 남여 20명을 대상으로 신맛, 조직감, 풍미 및 전제적인기호도를 5점 척도법으로 관능테스트를 실시하였으며, 그 결과를 아래 표 1에 나타내었다.The sour taste, texture, flavor, and overall acceptability of the soybean yogurt of Examples 1 to 8 and Comparative Examples 1 to 4 of the present invention were measured by a five-point scale method. The results are shown in Table 1 below.
강도(1~5)Sour taste
Strength (1 to 5)
점성(1~5)Texture
Viscosity (1 to 5)
기호(1~5)zest
Symbols (1 to 5)
기호(1~5)The total prayer
Symbols (1 to 5)
(모링가+콩단백질0.5)Example 5
(Moringa + soy protein 0.5)
(모링가+콩단백질1)Example 6
(Moringa + soy protein 1)
(모링가+콩단백질2)Example 7
(Moringa + Soy Protein 2)
(모링가+콩단백질3)Example 8
(Moringa + Soy Protein 3)
(두유액+단백질분해효소)Comparative Example 3
(Soy milk solution + protease)
(모링가+단백질분해효소)Comparative Example 4
(Moringa + protease)
관능테스트 결과 본 발명의 실시예 1 내지 8에 의해 제조된 콩요구르트의 기호도가 전체적으로 비교예 1 내지 4에 비해 높게 나타났으며, 특시 신맛의 강도가 비교예에 비해 실시예에서 낮게 나타났으며, 조작감도 비교예에 비해 실시예에서 현저하게 좋은 것으로 나타났다. As a result of the sensory test, the preference degree of the soybean yogurt produced according to Examples 1 to 8 of the present invention was higher than that of Comparative Examples 1 to 4 as a whole, and the intensity of the special sour taste was lower in the Examples than the Comparative Examples, The operation feeling was remarkably good in the examples as compared with the comparative examples.
<시험예 2>≪ Test Example 2 &
본 발명의 실시예 1 내지 8 및 비교예 1 내지 4의 콩요구르트에 대하여 보관 기간에 따른 유산균 생균수를 측정하여 그 결과를 하기 표 2에 나타내었다. The soybean yoghurts of Examples 1 to 8 and Comparative Examples 1 to 4 of the present invention were measured for the number of lactic acid bacteria viable cells during storage, and the results are shown in Table 2 below.
생균수After 1 day fermentation
Viable cell count
생균수Two weeks after refrigerated storage
Viable cell count
생균수4 weeks after cold storage
Viable cell count
(콩단백질0.5+단백질분해효소)Example 1
(Soy protein 0.5+ protease)
(콩단백질 1+단백질분해효소)Example 2
(Soy protein 1 + protease)
(콩단백질 2+단백질분해효소)Example 3
(Soy protein 2 + protease)
(콩단백질 3+단백질분해효소)Example 4
(Soy protein 3 + protease)
(모링가+콩단백질0.5+단백질분해효소)Example 5
(Moringa + soy protein 0.5+ protease)
(모링가+콩단백질1+단백질분해효소)Example 6
(Moringa + soy protein 1 + protease)
(모링가+콩단백질2+단백질분해효소)Example 7
(Moringa + Soy Protein 2+ Protease)
(모링가+콩단백질3+단백질분해효소)Example 8
(Moringa + Soy Protein 3+ Protease)
(두유액+단백질분해효소)Comparative Example 3
(Soy milk solution + protease)
(모링가+단백질분해효소)Comparative Example 4
(Moringa + protease)
유산균의 생균수 측정결과 본 발명의 실시예 1 내지 8의 콩요구르트가 비교예 1 내지 4의 콩요구르트에 비해 제조직후에 유산균의 생균수가 현저하게 높게 증식하는 것으로 나타났으며, 보관기간이 경과함에 따라서 사멸율도 비교예에 비해 실시예의 콩요구르트에서 현저하게 낮은 것으로 나타났다. As a result of measuring the number of viable cells of the lactic acid bacteria, the number of the lactic acid bacteria in the soybean yoghurts of Examples 1 to 8 was significantly higher than that of the soybean yoghurts of Comparative Examples 1 to 4, Therefore, the mortality rate was significantly lower in soy yogurt than the comparative example.
<시험예 3>≪ Test Example 3 >
상기 시험예 2의 결과를 바탕으로 단백질분해효소의 유무에 의한 유산균 생균수의 변화를 확인하기 위해 본 발명의 비교예 1과 비교예 5 및 실시예 3에 대하여 발효시간에 따른 유산균 생균수의 변화를 측정하였으며, 그 결과를 하기 표 3에 나타내었다. 또한, 본 발명의 비교예 5(미분해액)와 실시예 3(단백분해액)의 유산균 생균수의 변화를 도 2에 나타내었다. Based on the results of Test Example 2, in order to confirm the change in the number of lactic acid bacteria living bacteria caused by the presence or absence of proteolytic enzymes, the change in the number of lactic acid bacteria live cells according to fermentation time was compared with Comparative Example 1, Comparative Example 5 and Example 3 of the present invention And the results are shown in Table 3 below. Fig. 2 shows changes in the number of lactic acid bacteria living cells of Comparative Example 5 (non-degrading solution) of the present invention and Example 3 (protein decomposition solution).
그 결과, 본 발명의 단백질분해효소를 첨가한 본 발명의 실시예 3에서 단백질분해소를 첨가하지 않은 비교예 1 및 비교예 5에 비해 유산균 생균수가 약 50%가량 증가되는 것으로 나타났다. As a result, in Example 3 of the present invention in which the protease of the present invention was added, the number of lactic acid bacteria viable cells was increased by about 50% as compared with Comparative Example 1 and Comparative Example 5 in which the protein degrading agent was not added.
상기 시험예 1 내지 3의 결과를 살펴보면 두유액에 모링가분말과 콩단백질을 보강하고, 단백질분해효소와 혼합유산균을 함께 접종하여 발효시키는 경우, 기호도 면에서 비교예에 비해 실시예에서 현저하게 개선된 것으로 나타났으며, 유산균 생균수도 현저하게 늘어나며, 사멸율도 낮은 것을 알 수 있었다. When the results of the above Test Examples 1 to 3 were examined, it was found that when the soybean milk was fortified with Moringa powder and soybean protein and fermented by inoculating the protease with the mixed lactic acid bacteria, , The number of lactic acid bacteria was significantly increased, and the mortality rate was low.
Claims (8)
상기 1단계에서 불려진 대두를 80~100℃의 물에 10~20분 동안 침지하는 2단계;
상기 2단계에서 침지한 대두를 탈피하는 3단계;
상기 3단계에서 탈피한 대두에 대두 부피의 5~8배의 물을 넣고 마쇄하는 4단계;
상기 4단계에서 마쇄된 대두를 100~170메쉬의 필터로 여과하여 8~10Brix의 두유액을 수득하는 5단계;
상기 5단계에서 수득된 두유액에 두유액 100중량부에 대하여 콩단백질(Isolated soy protein) 0.5~3중량부와 당분 5~12중량부를 첨가하여 두유혼합액을 수득하는 6단계;
상기 6단계에서 수득한 두유혼합액을 살균하는 7단계;
상기 살균된 두유혼합액에 혼합유산균과 단백분해효소를 첨가하여 pH 4.2~4.6이 되도록 발효시키는 8단계; 및
상기 발효된 두유혼합액을 0~10℃의 냉장 온도에서 12~24시간 동안 숙성시키는 9단계를 포함하는 것을 특징으로 하는 기호성과 유산균의 생균수를 향상시킨 콩요구르트의 제조방법.
Soybeans are firstly called water at room temperature for 1 to 3 hours;
A step of soaking the so-called step 1 in water at 80 to 100 ° C for 10 to 20 minutes;
A step 3 for removing the soybean soaked in the step 2;
Step 4 is a step of putting 5 to 8 times as much water as soybeans in the soybeans soaked in the step 3 and grinding them;
Filtering the soybeans ground in step 4 with a filter having a size of 100 to 170 mesh to obtain a soy milk solution having a boiling point of 8 to 10 Brix;
0.5 to 3 parts by weight of isolated soy protein and 5 to 12 parts by weight of sugar are added to the soy milk solution obtained in the step 5 to obtain a soybean milk mixture solution in an amount of 100 parts by weight of soy milk solution;
Step 7 for sterilizing the soybean milk mixture obtained in step 6;
Adding lactic acid bacteria and proteolytic enzymes to the sterilized soybean milk mixture to ferment at a pH of 4.2 to 4.6; And
And 9) aging the fermented soybean milk mixture at a refrigeration temperature of 0 to 10 캜 for 12 to 24 hours, wherein the fermented soybean milk mixture is improved in palatability and viable cell count of lactic acid bacteria.
상기 4단계의 공정에서 탈피한 대두에 탈피한 대두 100중량부를 기준으로 모링가분말 0.5~5중량부를 첨가하여 함께 마쇄하는 것을 특징으로 하는 기호성과 유산균의 생균수를 향상시킨 콩요구르트의 제조방법.
The method according to claim 1,
Wherein 0.5 to 5 parts by weight of Moringa powder is added to 100 parts by weight of soybean melted in the process of step 4, and the resulting mixture is ground together, thereby improving the number of viable cells of the lactic acid bacterium.
상기 당분은 올리고당과 과당을 1:0.5~1.5의 중량비로 혼합한 것을 특징으로 하는 기호성과 유산균의 생균수를 향상시킨 콩요구르트의 제조방법.
The method according to claim 1,
Wherein the sugar is a mixture of oligosaccharide and fructose at a weight ratio of 1: 0.5 to 1.5, wherein the number of viable cells of the lactic acid bacterium is improved.
상기 혼합유산균은 L. casei , B. longum , L. acidophilus, 및 S. thermophilus의 균주가 하나 이상 혼합된 것을 특징으로 하는 기호성과 유산균의 생균수를 향상시킨 콩요구르트의 제조방법.
The method according to claim 1,
Wherein the mixed lactic acid bacteria is one or more strains of L. casei , B. longum , L. acidophilus, and S. thermophilus, wherein the strain has improved palatability and viable cell count of lactic acid bacteria.
상기 혼합유산균의 함량은 두유혼합액의 0.005~0.01중량%인 것을 특징으로 하는 기호성과 유산균의 생균수를 향상시킨 콩요구르트의 제조방법.
5. The method of claim 4,
Wherein the content of the mixed lactic acid bacterium is 0.005 to 0.01% by weight of the soybean milk mixed solution, wherein the number of viable bacteria of the lactic acid bacterium is improved.
상기 단백분해효소는 Protamex 및 Flavouzyme을 하나 이상 포함하는 것을 특징으로 하는 기호성과 유산균의 생균수를 향상시킨 콩요구르트의 제조방법.
The method according to claim 1,
Wherein the protease comprises at least one of Protamex and Flavouzyme, wherein the number of viable cells of the lactic acid bacterium is improved.
상기 단백분해효소의 함량은 두유혼합액의 0.01~0.05중량%인 것을 특징으로 하는 기호성과 유산균의 생균수를 향상시킨 콩요구르트의 제조방법.
The method according to claim 6,
Wherein the content of the proteolytic enzyme is 0.01 to 0.05% by weight of the soybean milk mixture, and the number of viable cells of the lactic acid bacteria is improved.
8. A soybean yogurt having improved palatability and viable cell count of lactic acid bacteria, which is produced by any one of claims 1 to 7.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020170111402A KR20190024420A (en) | 2017-08-31 | 2017-08-31 | Manufacturing method of soybean-yogurt improved taste and increased number of viable lactic acid bacteria |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020170111402A KR20190024420A (en) | 2017-08-31 | 2017-08-31 | Manufacturing method of soybean-yogurt improved taste and increased number of viable lactic acid bacteria |
Publications (1)
Publication Number | Publication Date |
---|---|
KR20190024420A true KR20190024420A (en) | 2019-03-08 |
Family
ID=65801276
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020170111402A KR20190024420A (en) | 2017-08-31 | 2017-08-31 | Manufacturing method of soybean-yogurt improved taste and increased number of viable lactic acid bacteria |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR20190024420A (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113388521A (en) * | 2021-05-27 | 2021-09-14 | 沈阳博阳饲料股份有限公司 | Diluent for delaying drop of viable count of liquid lactobacillus at normal temperature and preparation method thereof |
KR20210126864A (en) * | 2020-04-13 | 2021-10-21 | 군산대학교산학협력단 | Manufacturing method of lactic acid bacteria fermentation product for meal replacement and lactic acid bacteria fermentation product made thereby |
WO2023118443A1 (en) * | 2021-12-24 | 2023-06-29 | Compagnie Gervais Danone | Fermented plant-based compositions and processes of preparing the same |
WO2024047085A1 (en) * | 2022-08-31 | 2024-03-07 | Société des Produits Nestlé S.A. | Fermented plant compositions containing oil bodies |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20110120007A (en) | 2010-04-28 | 2011-11-03 | 부산대학교 산학협력단 | Fermented soymilk with high fructionality and sensory properties and the method thereof |
KR20110120802A (en) | 2010-04-29 | 2011-11-04 | 부산대학교 산학협력단 | A novel b. subtilis sp. strain and fermented soymilk for anti-gastric cancer by using the same |
-
2017
- 2017-08-31 KR KR1020170111402A patent/KR20190024420A/en not_active Application Discontinuation
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20110120007A (en) | 2010-04-28 | 2011-11-03 | 부산대학교 산학협력단 | Fermented soymilk with high fructionality and sensory properties and the method thereof |
KR20110120802A (en) | 2010-04-29 | 2011-11-04 | 부산대학교 산학협력단 | A novel b. subtilis sp. strain and fermented soymilk for anti-gastric cancer by using the same |
Non-Patent Citations (2)
Title |
---|
관능성 및 기능성이 뛰어난 발효두유 및 이의 제조방법(Fermented Soymilk with High Fructionality and Sensory properties and the Method thereof) |
기능성 발효두유 및 그 추출물을 함유하는 위암 예방용 약학적 조성물(A novel B. Subtilis sp. strain and fermented soymilk for anti-gastric cancer by using the same) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20210126864A (en) * | 2020-04-13 | 2021-10-21 | 군산대학교산학협력단 | Manufacturing method of lactic acid bacteria fermentation product for meal replacement and lactic acid bacteria fermentation product made thereby |
CN113388521A (en) * | 2021-05-27 | 2021-09-14 | 沈阳博阳饲料股份有限公司 | Diluent for delaying drop of viable count of liquid lactobacillus at normal temperature and preparation method thereof |
WO2023118443A1 (en) * | 2021-12-24 | 2023-06-29 | Compagnie Gervais Danone | Fermented plant-based compositions and processes of preparing the same |
WO2024047085A1 (en) * | 2022-08-31 | 2024-03-07 | Société des Produits Nestlé S.A. | Fermented plant compositions containing oil bodies |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR101938315B1 (en) | Method of manufacturing health food and beverage using Bacillus megaterium strain and its food and beverage | |
KR101152917B1 (en) | Nutrition balanced yogurt fermented from soy bean milk and milk by kimchi and milk lactic acid bacteria complex and a method of manufacture thereof | |
KR20190024420A (en) | Manufacturing method of soybean-yogurt improved taste and increased number of viable lactic acid bacteria | |
KR102149951B1 (en) | Fermented material of jujube with high gaba by mixed fermentation and manufacturing method thereof | |
CN104856153A (en) | Composite blueberry purple potato black kerneled rice lactic acid beverage and preparation method thereof | |
CN108041388B (en) | Processing technology of alcohol-free fermented grape beverage | |
CN111034996A (en) | Preparation method of apple enzyme functional beverage | |
JP6955808B1 (en) | How to make fermented honey | |
KR102394733B1 (en) | Method for producing fermented spinach and fermented soybean with increased effective component content using lactic acid bacteria | |
KR20220025680A (en) | Method for producing fermented balloon flower postbiotics with increased effective component content using lactic acid bacteria | |
CN103598331A (en) | Rehmannia root functional yoghourt, rehmannia root blueberry functional yoghourt and preparation method thereof | |
KR102387269B1 (en) | Composition and method for yogurt with enhanced GABA using barley and yogurt produced by the same | |
CN108029921A (en) | A kind of Chinese pear-leaved crabapple fermented beverage and preparation method thereof | |
CN104026235A (en) | Cranberry collagen polypeptide Ca yoghurt | |
CN113693205A (en) | Healthy flavored soybean milk formula and production process thereof | |
CN104026246B (en) | A kind of flavor fermentation soya-bean milk formula and preparation method | |
KR101498226B1 (en) | Funtional drink by mixed fermentation of oak mushrooms extract and whey and manufacturing metond thereof | |
KR100378154B1 (en) | A functional yogurt using a mushroom and process for preparation thereof | |
KR20120124080A (en) | Method for Preparing Soy Sikhye Yogurt and the Soy Sikhye Yogurt Prepared by the Same Method | |
KR102427965B1 (en) | Method for Selecting Lactic Acid Bacteria Complex for Development of Fermentation Food | |
JP2003116502A (en) | Method for producing fermented vegetable lactic acid beverage and sweetener used for non-alcohol beverage | |
KR101403593B1 (en) | Yogurt comprising barley and preparation method thereof | |
CN113331331A (en) | Preparation method of probiotic fermented beverage | |
KR101784091B1 (en) | Method for Producing Fermented Milk with Berries and Fermented Milk Thereby | |
KR20170097248A (en) | Fermented composition, fermented beverage comprising the same and method for preparing thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E601 | Decision to refuse application |